Red Cross Says Biotech's Antitrust Suit Makes No Sense

By Chris Villani · April 18, 2023, 5:49 PM EDT

The American Red Cross on Monday blasted a biotech company's suit claiming it's trying to snuff out competition in platelet bacteria mitigation, arguing the case "makes no sense" and would allow...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

February 14, 2023

Recent Articles By Chris

November 13, 2024
Mass. AG Ready To Reprise Office's Role As Trump Foil
August 12, 2024
Big Tobacco To Pay $600M In 'Historic' Mass. Deal
July 23, 2024
'Surface Water' Stumps Mass. Justices In Loss For Insurers
July 12, 2024
Feds Say Fake Gunshot Wounds Part Of $1M Fraud Scheme
March 01, 2024
GSK, Shook Hardy Can Recover Costs After Zofran MDL Win
February 26, 2024
Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case
February 20, 2024
Justices Decline Malpractice Dispute Over $6M Settlement
December 21, 2023
The 5 Biggest First Circuit Rulings Of 2023
December 20, 2023
No Discovery In Regeneron FCA Case Until 1st Circ. Rules
November 21, 2023
Ex-Aegerion Rep Cops To Fraud, Avoiding Trial Redo